ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $40,874,783,000 | +42.9% | 237,506 | +4.2% | 0.02% | +41.7% |
| Q2 2021 | $28,597,791,000 | +10.6% | 227,889 | +19.5% | 0.01% | +9.1% |
| Q1 2021 | $25,868,150,000 | -15.3% | 190,754 | -20.1% | 0.01% | -21.4% |
| Q4 2020 | $30,545,547,000 | +16.3% | 238,749 | +2.3% | 0.01% | 0.0% |
| Q3 2020 | $26,255,836,000 | +5.3% | 233,323 | -10.8% | 0.01% | -6.7% |
| Q2 2020 | $24,924,919,000 | +7.7% | 261,624 | +1.6% | 0.02% | -11.8% |
| Q1 2020 | $23,146,469,000 | +25.9% | 257,555 | -25.7% | 0.02% | +54.5% |
| Q4 2019 | $18,390,092,000 | +47.8% | 346,852 | +10.1% | 0.01% | +37.5% |
| Q3 2019 | $12,444,188,000 | -13.7% | 314,963 | -10.3% | 0.01% | -20.0% |
| Q2 2019 | $14,416,984,000 | -10.4% | 350,949 | +1.6% | 0.01% | -16.7% |
| Q1 2019 | $16,090,121,000 | +5.4% | 345,504 | -1.4% | 0.01% | -7.7% |
| Q4 2018 | $15,262,490,000 | -5.9% | 350,459 | +23.7% | 0.01% | +8.3% |
| Q3 2018 | $16,212,285,000 | +1.8% | 283,283 | -13.7% | 0.01% | 0.0% |
| Q2 2018 | $15,918,442,000 | -1.3% | 328,080 | -20.4% | 0.01% | -7.7% |
| Q1 2018 | $16,121,322,000 | -12.7% | 412,310 | -5.3% | 0.01% | -18.8% |
| Q4 2017 | $18,476,806,000 | +52.1% | 435,363 | +33.8% | 0.02% | +45.5% |
| Q3 2017 | $12,145,794,000 | +24.6% | 325,450 | +1.5% | 0.01% | +22.2% |
| Q2 2017 | $9,747,045,000 | +2538193.0% | 320,732 | +2925.8% | 0.01% | – |
| Q3 2016 | $384,000 | +6.7% | 10,600 | 0.0% | 0.00% | – |
| Q2 2016 | $360,000 | +28.6% | 10,600 | 0.0% | 0.00% | – |
| Q1 2016 | $280,000 | -96.7% | 10,600 | -93.9% | 0.00% | -100.0% |
| Q4 2015 | $8,447,000 | +180.6% | 173,224 | +43.3% | 0.01% | +233.3% |
| Q3 2015 | $3,010,000 | -17.8% | 120,897 | +4.4% | 0.00% | -25.0% |
| Q2 2015 | $3,663,000 | -13.1% | 115,792 | +4.6% | 0.00% | 0.0% |
| Q1 2015 | $4,213,000 | -4.6% | 110,700 | -2.4% | 0.00% | 0.0% |
| Q4 2014 | $4,418,000 | +26.3% | 113,400 | -2.0% | 0.00% | +33.3% |
| Q3 2014 | $3,499,000 | -14.7% | 115,700 | -4.2% | 0.00% | -25.0% |
| Q2 2014 | $4,104,000 | +84.1% | 120,800 | +87.0% | 0.00% | +100.0% |
| Q1 2014 | $2,229,000 | -13.5% | 64,600 | -0.8% | 0.00% | -33.3% |
| Q4 2013 | $2,578,000 | – | 65,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |